<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="164737">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01809197</url>
  </required_header>
  <id_info>
    <org_study_id>M-12-056</org_study_id>
    <nct_id>NCT01809197</nct_id>
  </id_info>
  <brief_title>Silicone Hydrogel Contact Lens Clinical and Comfort Benefits With a Multi-Purpose Disinfecting Solution</brief_title>
  <official_title>Silicone Hydrogel Contact Lens Clinical and Comfort Benefits With a Multi-Purpose Disinfecting Solution</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare comfort between two systems of contact lens+contact
      lens care.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prior to the 30-day study period, participants will be fitted with study lenses in a masked
      manner and undergo a run-in period of 4-8 days to adjust to the randomized lenses.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Likert Item: &quot;I can comfortably wear my lenses&quot;</measure>
    <time_frame>Day 30</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">368</enrollment>
  <condition>Refractive Error</condition>
  <condition>Myopia</condition>
  <condition>Hyperopia</condition>
  <condition>Astigmatism</condition>
  <condition>Presbyopia</condition>
  <arm_group>
    <arm_group_label>Lotrafilcon B/OPTI-FREE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lotrafilcon B contact lenses worn on a daily wear basis for 30 days, with OPTI-FREE MPDS lens care system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Senofilcon A/Habitual MPS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Senofilcon A contact lenses worn on a daily wear basis for 30 days, with habitual MPS lens care system</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lotrafilcon B contact lenses</intervention_name>
    <description>Silicone hydrogel contact lenses for near/far-sightedness, astigmatism, and/or presbyopia, replaced per manufacturer's instructions</description>
    <arm_group_label>Lotrafilcon B/OPTI-FREE</arm_group_label>
    <other_name>AIR OPTIX® AQUA</other_name>
    <other_name>AIR OPTIX® AQUA Multifocal</other_name>
    <other_name>AIR OPTIX® for Astigmatism</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Senofilcon A contact lenses</intervention_name>
    <description>Silicone hydrogel contact lenses for near/far-sightedness, astigmatism, and/or presbyopia, replaced per manufacturer's instructions</description>
    <arm_group_label>Senofilcon A/Habitual MPS</arm_group_label>
    <other_name>ACUVUE® OASYS® with HYDRACLEAR® PLUS</other_name>
    <other_name>ACUVUE® OASYS® for ASTIGMATISM with HYDRACLEAR® PLUS</other_name>
    <other_name>ACUVUE® OASYS® for PRESBYOPIA with HYDRACLEAR® PLUS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OPTI-FREE PureMoist Multi-Purpose Disinfecting Solution (MPDS)</intervention_name>
    <description>Multi-purpose disinfecting solution for contact lens care, used per manufacturer's instructions</description>
    <arm_group_label>Lotrafilcon B/OPTI-FREE</arm_group_label>
    <other_name>OPTI-FREE® PureMoist™</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Habitual Multi-Purpose Solution (MPS)</intervention_name>
    <description>Multi-purpose solution for contact lens care according to participant's habitual brand, used per manufacturer's instructions</description>
    <arm_group_label>Senofilcon A/Habitual MPS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sign informed consent.

          -  Currently wearing weekly/monthly contact lenses on a daily wear basis, as specified
             in protocol.

          -  Willing to wear contact lenses on a daily wear basis for the duration of the study.

          -  Currently using a multi-purpose solution, as specified in protocol.

          -  Vision correctable to 20/30 (Snellen) or better in each eye at distance at Visit 1.

          -  Willing to follow the study procedures and visit schedule.

          -  Other protocol-defined inclusion criteria may apply.

        Exclusion Criteria:

          -  Currently wearing any Air Optix or Acuvue brand of silicone hydrogel contact lenses.

          -  Currently using any Opti-Free brand of multi-purpose solution.

          -  Must wear contact lenses on an extended wear (overnight) basis during the study.

          -  Known sensitivity or intolerance to POLYQUAD or ALDOX preserved lens care products.

          -  Monocular (only one eye with functional vision), fit with only one lens, or
             monovision modality of wear.

          -  Use of additional lens care products other than a multi-purpose solution within 7
             days prior to Visit 1.

          -  Use of topical ocular over-the-counter (OTC) or prescribed topical ocular
             medications, with the exception of contact lens rewetting drops, within 7 days prior
             to Visit 1.

          -  Any abnormal ocular condition observed during the Visit 1 slit-lamp examination.

          -  Current or history of ocular infections (i.e., microbial keratitis, conjunctivitis)
             or severe inflammation (i.e., iritis, infiltrates) within the 6 months prior to Visit
             1.

          -  Ocular surgery within the 12 months prior to Visit 1.

          -  Any systemic diseases at Visit 1 (including allergies, respiratory infections or
             colds) that affect the eye and could be exacerbated by use of contact lenses or
             contact lens solutions.

          -  Participation in any clinical study within 30 days of Visit 1.

          -  Other protocol-defined exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jessie Lemp, MS</last_name>
    <role>Study Director</role>
    <affiliation>Alcon Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Contact Alcon Call Center for Trial Locations</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 20, 2013</lastchanged_date>
  <firstreceived_date>March 8, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Refractive error</keyword>
  <keyword>Myopia</keyword>
  <keyword>Hyperopia</keyword>
  <keyword>Astigmatism</keyword>
  <keyword>Presbyopia</keyword>
  <keyword>Contact lenses</keyword>
  <keyword>Contact lens solution</keyword>
  <keyword>Comfort</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Astigmatism</mesh_term>
    <mesh_term>Hyperopia</mesh_term>
    <mesh_term>Myopia</mesh_term>
    <mesh_term>Presbyopia</mesh_term>
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Contact Lens Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
